Biotechl companies use the insights from the patient information such as mutation profiles and patient metadata. This information helps the researchers to develop models and find statistical relationships between the attributes.

This way, companies can design drugs that address the key mutations in the genetic sequences. Also, deep learning algorithms can find the probability of the development of disease in the human system.

The data science algorithms can also help to simulate how the drugs will act in the human body that takes away the long laboratory experimentations.